PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
29,083,626
Share change
+239,020
Total reported value
$56,709,997
Put/Call ratio
80%
Price per share
$1.95
Number of holders
32
Value change
+$1,821,247
Number of buys
13
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q2 2015

As of 30 Jun 2015, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,083,626 shares. The largest 10 holders included FEDERATED INVESTORS INC /PA/, Camber Capital Management LLC, BAILLIE GIFFORD & CO, Visium Asset Management, LP, DAFNA Capital Management LLC, MENORA MIVTACHIM HOLDINGS LTD., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management), BRIDGEWAY CAPITAL MANAGEMENT INC, and STATE OF WISCONSIN INVESTMENT BOARD. This page lists 32 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.